Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature

Molecular changes in the primary breast cancer versus the relapsed/metastatic lesion from a large population-based database and tissue microarray series

(2017) R. MacFarlane et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

(2009) C. Liedtke et al.   ANNALS OF ONCOLOGY

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

(2009) C. Simmons et al.   ANNALS OF ONCOLOGY

HER-2/neu expression in primary and metastatic breast cancer

(2008) Elyse E. Lower et al.   BREAST CANCER RESEARCH AND TREATMENT

Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases

(2008) J. M. Wu et al.   CLINICAL CANCER RESEARCH

Does HER‐2/neu antigen loss in metastatic breast tumors occur under immune pressure?

(2008) Masoud H. Manjili et al.   INTERNATIONAL JOURNAL OF CANCER

Current issues in ER and HER2 testing by IHC in breast cancer

(2008) Allen M Gown   MODERN PATHOLOGY

Comparison of HER-2 and Hormone Receptor Expression in Primary Breast Cancers and Asynchronous Paired Metastases: Impact on Patient Management

(2008) V. Guarneri et al.   ONCOLOGIST